GrittGene
Menu

Success is achieved through

Focus, Speed & GRITT

We are designing the right Road Map using the right Technology, Science, Platform and Pipelines
Our platform produces a diversified pipeline across:

Cell Therapy – regenerative strategies for muscle repair

Gene Therapy – targeted genetic interventions

Biologics – precision modulation of disease pathways

Diagnostics – enabling detection and disease monitoring

Designed for multiple independent shots on goal, our pipeline distributes risk while maximizing value creation across modalities. While DM2 is our initial focus, our platform is inherently scalable. Our muscle regeneration cell therapy programs extend beyond DM2 into broader neuromuscular diseases and age-related muscle loss (sarcopenia)—large and underserved markets with significant need.